# SYFOVRE
> **NDA217171** · New Drug Application · Sponsor: APELLIS PHARMS · Approved 2023-02-17
## Drug
- **FDA Application Number:** NDA217171
- **Application type:** New Drug Application
- **Brand name:** SYFOVRE
- **Generic name:** PEGCETACOPLAN
- **Active ingredients:** PEGCETACOPLAN
- **Dosage form:** SOLUTION
- **Route:** INTRAVITREAL
- **Marketing status:** Prescription
- **Sponsor:** APELLIS PHARMS
- **Manufacturer:** Apellis Pharmaceuticals, Inc.
- **First approval:** 2023-02-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217171)
---
*AI Analytics · CC0 1.0*